MedPath
HSA Product

ROYCE RIFAMPICIN CAPSULE 300MG

Product approved by Health Sciences Authority (SG)

Basic Information

ROYCE RIFAMPICIN CAPSULE 300MG

CAPSULE

Regulatory Information

SIN16653P

December 7, 2022

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XJ04AB02

Company Information

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Active Ingredients

Rifampicin

Strength: 300mg

Detailed Information

Contraindications

**Contraindication :** Jaundice; hypersensitivity to Rifampicin antibiotics; first trimester of pregnancy; premature and newborn infants; are concurrently receiving saquinavir/ritonavir therapy.

Indication Information

**Indication :** Royce Rifampicin Capsule used in combination with other active antituberculosis drugs is indicated in the treatment of all forms of tuberculosis. It is also effective against many atypical strains of mycobacteria.

© Copyright 2025. All Rights Reserved by MedPath